Vara

Vara is a healthcare AI company revolutionizing breast cancer screening with FDA-cleared and CE-certified (Class IIb) AI software that enhances radiologist accuracy and efficiency. Deployed at scale within Germany's National Breast Cancer Screening Program—where nearly 40% of national screening runs on Vara's platform—its AI identifies 43% more cancers that radiologists might miss while reducing radiologist workload by up to 73%. The PRAIM Study demonstrated a 17.6% improvement in cancer detection rates across 500,000 participants. Vara operates in Germany, India, Egypt, and Mexico in partnership with radiology service providers and healthcare networks.